Literature DB >> 19147446

Cardiac resynchronization therapy and atrial overdrive pacing for the treatment of central sleep apnoea.

Lars Lüthje1, Bernd Renner, Roger Kessels, Dirk Vollmann, Tobias Raupach, Bart Gerritse, Selcuk Tasci, Jörg O Schwab, Markus Zabel, Dieter Zenker, Peter Schott, Gerd Hasenfuss, Christina Unterberg-Buchwald, Stefan Andreas.   

Abstract

AIMS: The combined therapeutic impact of atrial overdrive pacing (AOP) and cardiac resynchronization therapy (CRT) on central sleep apnoea (CSA) in chronic heart failure (CHF) so far has not been investigated. We aimed to evaluate the effect of CRT alone and CRT + AOP on CSA in CHF patients and to compare the influence of CRT on CHF between CSA positive and CSA negative patients. METHODS AND
RESULTS: Thirty patients with CRT indication underwent full night polysomnography, echocardiography, exercise testing, and neurohumoral evaluation before and 3 months after CRT implantation. In CSA positive patients (60%), two additional sleep studies were conducted after 3 months of CRT, with CRT alone or CRT + AOP, in random order. Cardiac resynchronization therapy resulted in significant improvements of NYHA class, left ventricular ejection fraction, N-terminal pro-brain natriuretic peptide, VO(2)max, and quality of life irrespective of the presence of CSA. Cardiac resynchronization therapy also reduced the central apnoea-hypopnoea index (AHI) (33.6 +/- 14.3 vs. 23.8 +/- 16.9 h(-1); P < 0.01) and central apnoea index (17.3 +/- 14.1 vs. 10.9 +/- 13.9 h(-1); P < 0.01) without altering sleep stages. Cardiac resynchronization therapy with atrial overdrive pacing resulted in a small but significant additional decrease of the central AHI (23.8 +/- 16.9 vs. 21.5 +/- 16.9 h(-1); P < 0.01).
CONCLUSION: In this study, CRT significantly improved CSA without altering sleep stages. Cardiac resynchronization therapy with atrial overdrive pacing resulted in a significant but minor additional improvement of CSA. Positive effects of CRT were irrespective of the presence of CSA.

Entities:  

Mesh:

Year:  2009        PMID: 19147446      PMCID: PMC2645047          DOI: 10.1093/eurjhf/hfn042

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  36 in total

1.  Influence of cardiac resynchronisation therapy on different types of sleep disordered breathing.

Authors:  Olaf Oldenburg; Lothar Faber; Jürgen Vogt; Anja Dorszewski; Florian Szabados; Dieter Horstkotte; Barbara Lamp
Journal:  Eur J Heart Fail       Date:  2007-04-27       Impact factor: 15.534

2.  Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure.

Authors:  D D Sin; F Fitzgerald; J D Parker; G Newton; J S Floras; T D Bradley
Journal:  Am J Respir Crit Care Med       Date:  1999-10       Impact factor: 21.405

3.  Long term biventricular resynchronisation therapy in advanced heart failure: effect on neurohormones.

Authors:  M U Braun; T Rauwolf; T Zerm; M Schulze; A Schnabel; R H Strasser
Journal:  Heart       Date:  2005-05       Impact factor: 5.994

4.  Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure.

Authors:  P A Lanfranchi; A Braghiroli; E Bosimini; G Mazzuero; R Colombo; C F Donner; P Giannuzzi
Journal:  Circulation       Date:  1999-03-23       Impact factor: 29.690

5.  Overdrive atrial pacing does not improve obstructive sleep apnoea syndrome.

Authors:  J-L Pépin; P Defaye; S Garrigue; Y Poezevara; P Lévy
Journal:  Eur Respir J       Date:  2005-02       Impact factor: 16.671

6.  Cardiac resynchronization induces favorable neurohumoral changes.

Authors:  Ayten Erol-Yilmaz; Hein J Verberne; Tim A Schrama; Jana Hrudova; Robbert J De Winter; Berthe L F Van Eck-Smit; Rianne De Bruin; Jeroen J Bax; Martin J Schalij; Arthur A Wilde; Raymond Tukkie
Journal:  Pacing Clin Electrophysiol       Date:  2005-04       Impact factor: 1.976

7.  Patient selection for cardiac resynchronization therapy: from the Council on Clinical Cardiology Subcommittee on Electrocardiography and Arrhythmias and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society.

Authors:  S Adam Strickberger; Jamie Conti; Emile G Daoud; Edward Havranek; Mandeep R Mehra; Ileana L Piña; James Young
Journal:  Circulation       Date:  2005-04-26       Impact factor: 29.690

8.  Improvement of exercise capacity with treatment of Cheyne-Stokes respiration in patients with congestive heart failure.

Authors:  S Andreas; C Clemens; H Sandholzer; H R Figulla; H Kreuzer
Journal:  J Am Coll Cardiol       Date:  1996-05       Impact factor: 24.094

9.  Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP).

Authors:  Michael Arzt; John S Floras; Alexander G Logan; R John Kimoff; Frederic Series; Debra Morrison; Kathleen Ferguson; Israel Belenkie; Michael Pfeifer; John Fleetham; Patrick Hanly; Mark Smilovitch; Clodagh Ryan; George Tomlinson; T Douglas Bradley
Journal:  Circulation       Date:  2007-06-11       Impact factor: 29.690

10.  Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea.

Authors:  M T Naughton; D C Benard; P P Liu; R Rutherford; F Rankin; T D Bradley
Journal:  Am J Respir Crit Care Med       Date:  1995-08       Impact factor: 21.405

View more
  16 in total

Review 1.  Sleep-disordered breathing and cardiovascular disorders.

Authors:  Rohit Budhiraja; Pooja Budhiraja; Stuart F Quan
Journal:  Respir Care       Date:  2010-10       Impact factor: 2.258

Review 2.  Dynamic CO₂ inhalation: a novel treatment for CSR-CSA associated with CHF.

Authors:  Zhi Hui Wan; Fang Jing Wen; Ke Hu
Journal:  Sleep Breath       Date:  2012-05-24       Impact factor: 2.816

Review 3.  The treatment of central sleep apnea syndromes in adults: practice parameters with an evidence-based literature review and meta-analyses.

Authors:  R Nisha Aurora; Susmita Chowdhuri; Kannan Ramar; Sabin R Bista; Kenneth R Casey; Carin I Lamm; David A Kristo; Jorge M Mallea; James A Rowley; Rochelle S Zak; Sharon L Tracy
Journal:  Sleep       Date:  2012-01-01       Impact factor: 5.849

4.  Overdrive ventricular pacing in pacemaker recipients with permanent atrial fibrillation and sleep apnea.

Authors:  Philippe Bordier; Sylvie Maurice-Tison; Nishi Krishna Ramana
Journal:  J Clin Sleep Med       Date:  2012-06-15       Impact factor: 4.062

5.  [Sleep-disordered breathing and cardiac resynchronization therapy].

Authors:  A-M Sinha
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2012-03

Review 6.  Continuous positive airway pressure and cardiovascular events in patients with obstructive sleep apnea.

Authors:  Athanasia Pataka; Renata L Riha
Journal:  Curr Cardiol Rep       Date:  2013-08       Impact factor: 2.931

7.  Therapy for sleep hypoventilation and central apnea syndromes.

Authors:  Bernardo J Selim; Mithri R Junna; Timothy I Morgenthaler
Journal:  Curr Treat Options Neurol       Date:  2012-10       Impact factor: 3.598

8.  Targeting Sleep Disordered Breathing to Prevent Heart Failure: What is the Evidence?

Authors:  Kenya Kusunose; Reena Mehra
Journal:  Curr Cardiovasc Risk Rep       Date:  2014-10-01

9.  Short- and long-term effects of nocturnal oxygen therapy on sleep apnea in chronic heart failure.

Authors:  Philippe Bordier; Sebastien Orazio; Pauline Hofmann; Frederic Robert; Ghalia Bourenane
Journal:  Sleep Breath       Date:  2014-04-15       Impact factor: 2.816

Review 10.  Management of Sleep Disordered Breathing in Patients with Heart Failure.

Authors:  Connor P Oates; Manjula Ananthram; Stephen S Gottlieb
Journal:  Curr Heart Fail Rep       Date:  2018-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.